Rohit Aggarwal

Rohit Aggarwal

University of Pittsburgh

H-index: 47

North America-United States

About Rohit Aggarwal

Rohit Aggarwal, With an exceptional h-index of 47 and a recent h-index of 40 (since 2020), a distinguished researcher at University of Pittsburgh, specializes in the field of Rheumatology, Connective Tissue Diseases, Myositis, Lupus, Rheumatoid Arthritis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey

COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

Evaluation of Autoantibody Status Effect on Dermatomyositis Patients’ Response to IVIG Treatment: Post-hoc Analysis of the ProDERM Trial (P4-14.007)

Flares of autoimmune rheumatic disease following COVID‐19 infection: Observations from the COVAD study

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative …

Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group …

A patient-centred assessment of the 2016 ACR-EULAR Myositis Response Criteria: evaluating the meaningfulness of responses

Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study

Rohit Aggarwal Information

University

Position

___

Citations(all)

9748

Citations(since 2020)

6767

Cited By

5050

hIndex(all)

47

hIndex(since 2020)

40

i10Index(all)

102

i10Index(since 2020)

91

Email

University Profile Page

Google Scholar

Rohit Aggarwal Skills & Research Interests

Rheumatology

Connective Tissue Diseases

Myositis

Lupus

Rheumatoid Arthritis

Top articles of Rohit Aggarwal

Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey

Rheumatology Advances in Practice

2024/1/1

COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

Rheumatology international

2024/1

Evaluation of Autoantibody Status Effect on Dermatomyositis Patients’ Response to IVIG Treatment: Post-hoc Analysis of the ProDERM Trial (P4-14.007)

2024/4/14

Mazen Dimachkie
Mazen Dimachkie

H-Index: 34

Rohit Aggarwal
Rohit Aggarwal

H-Index: 32

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative …

2023/12

Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group …

2024/3/28

A patient-centred assessment of the 2016 ACR-EULAR Myositis Response Criteria: evaluating the meaningfulness of responses

Rheumatology

2024/3/9

Rohit Aggarwal
Rohit Aggarwal

H-Index: 32

Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study

Rheumatology

2024/3/2

P134 Factors associated with discordance between patient and physician perception of disease activity among patients with systemic lupus erythematosus: an international …

2024/3/1

Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

Rheumatology international

2024/1

P132 Exploring the impact of comorbidity, multimorbidity, and mental health conditions on health related outcomes in systemic lupus erythematous: a global study

2024/3/1

P152 Exploring global discrepancies in systemic lupus erythematosus treatment

2024/3/1

Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study

Rheumatology

2024/3/1

Pain is common in myositis and associated with disease activity

Rheumatology

2024/2/26

Rohit Aggarwal
Rohit Aggarwal

H-Index: 32

5th Global Conference on Myositis (GCOM)

Clinical and experimental rheumatology

2024/2

Rohit Aggarwal
Rohit Aggarwal

H-Index: 32

Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review

Arthritis & rheumatology (Hoboken, NJ)

2022/3

A review of the evidence for the utility of physical activity monitor use in patients with idiopathic inflammatory myopathies

2024/1/18

Bonny Rockette-Wagner
Bonny Rockette-Wagner

H-Index: 8

Rohit Aggarwal
Rohit Aggarwal

H-Index: 32

Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study

Arthritis Research & Therapy

2024/1/17

Rohit Aggarwal
Rohit Aggarwal

H-Index: 32

Zoltan Griger
Zoltan Griger

H-Index: 8

See List of Professors in Rohit Aggarwal University(University of Pittsburgh)

Co-Authors

academic-engine